Induction and Maintenance of Clinical Remission by Adalimumab in Patients With Moderate-to-Severe Ulcerative Colitis

被引:1
|
作者
Sandborn, William J.
Van Assche, Gert A.
Reinisch, Walter
Colombel, Jean-Frederic
D'Haens, Geert R.
Wolf, Douglas C.
Kron, Martina
Tighe, Mary Beth
Lazar, Andreas
Thakkar, Roopal
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S123 / S124
页数:2
相关论文
共 50 条
  • [41] CURRENT LANDSCAPE AND TREATMENTS USED IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Siegel, C. A.
    Seigel, L.
    Verma, S.
    Sruti, I
    Mu, Q.
    Gupte, K.
    VALUE IN HEALTH, 2021, 24 : S99 - S99
  • [42] Histological remission in patients with moderate-to-severe ulcerative colitis undergoing biological therapy: a single-centre experience
    Di Ruscio, M.
    Variola, A.
    Geccherle, A.
    Lunardi, G.
    Castelli, P.
    Zamboni, G.
    Riddell, R.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S441 - S442
  • [43] OLSALAZINE IN MAINTENANCE OF CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE-COLITIS
    WRIGHT, JP
    OKEEFE, EA
    CUMING, L
    JASKIEWICZ, K
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1837 - 1842
  • [44] An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis
    Johnson, Amanda M.
    Loftus Jr, Edward V.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (12) : 1317 - 1327
  • [45] First Oral Drug for Moderate-To-Severe Ulcerative Colitis
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (09) : 22 - 22
  • [46] Spotlight: Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
    Singh, Siddharth
    Loftus Jr, Edward V.
    Limketkai, Berkeley N.
    Haydek, John P.
    Agrawalm, Manasi
    Scott, Frank I.
    Ananthakrishnan, Ashwin N.
    GASTROENTEROLOGY, 2024, 167 (07) : 1344 - 1344
  • [48] A Case of Successful Remission in Moderate-to-Severe Steroid Refractory Ulcerative Colitis Using Herbal Therapy
    Lee, Alice
    Mandaliya, Rohan
    Mattar, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1103 - S1104
  • [49] Safety evaluation of ustekinumab for moderate-to-severe ulcerative colitis
    Miyoshi, Jun
    Matsuura, Minoru
    Hisamatsu, Tadakazu
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 1 - 8
  • [50] Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Taxonera, C.
    Estelles, J.
    Fernandez-Blanco, I.
    Merino, O.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Saro, C.
    Garcia-Sanchez, V.
    Gento, E.
    Bastida, G.
    Gisbert, J. P.
    Vera, I.
    Martinez-Montiel, P.
    Garcia-Moran, S.
    Sanchez, M. C.
    Mendoza, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 340 - 348